Report Detail
Global Bio Similars/Subsequent Entry Biologic Market Growth (Status and Outlook) 2019-2024
- RnM3411970 |
- 13 May, 2019 |
- Global |
- 158 Pages |
- LPI(LP Information) |
- Other
According to this study, over the next five years the Bio Similars/Subsequent Entry Biologic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Bio Similars/Subsequent Entry Biologic business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Bio Similars/Subsequent Entry Biologic market by product type, application, key companies and key regions.
This study considers the Bio Similars/Subsequent Entry Biologic value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Bio Similars/Subsequent Entry Biologic market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Bio Similars/Subsequent Entry Biologic market by identifying its various subsegments.
Focuses on the key global Bio Similars/Subsequent Entry Biologic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bio Similars/Subsequent Entry Biologic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Bio Similars/Subsequent Entry Biologic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Bio Similars/Subsequent Entry Biologic Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Bio Similars/Subsequent Entry Biologic Market Size 2014-2024
- 2.1.2 Bio Similars/Subsequent Entry Biologic Market Size CAGR by Region
- 2.2 Bio Similars/Subsequent Entry Biologic Segment by Type
- 2.2.1 Monoclonal Antibodies
- 2.2.2 Interferon
- 2.2.3 Erythropoietin
- 2.2.4 Insulin
- 2.2.5 Vaccines
- 2.2.6 Other
- 2.3 Bio Similars/Subsequent Entry Biologic Market Size by Type
- 2.3.1 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Type (2014-2019)
- 2.4 Bio Similars/Subsequent Entry Biologic Segment by Application
- 2.4.1 Tumor
- 2.4.2 Diabetes
- 2.4.3 Cardiovascular
- 2.4.4 Hemophilia
- 2.4.5 Other
- 2.5 Bio Similars/Subsequent Entry Biologic Market Size by Application
- 2.5.1 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Bio Similars/Subsequent Entry Biologic Market Size Growth Rate by Application (2014-2019)
3 Global Bio Similars/Subsequent Entry Biologic by Players
- 3.1 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Players
- 3.1.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Players (2017-2019)
- 3.1.2 Global Bio Similars/Subsequent Entry Biologic Market Size Market Share by Players (2017-2019)
- 3.2 Global Bio Similars/Subsequent Entry Biologic Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Bio Similars/Subsequent Entry Biologic by Regions
- 4.1 Bio Similars/Subsequent Entry Biologic Market Size by Regions
- 4.2 Americas Bio Similars/Subsequent Entry Biologic Market Size Growth
- 4.3 APAC Bio Similars/Subsequent Entry Biologic Market Size Growth
- 4.4 Europe Bio Similars/Subsequent Entry Biologic Market Size Growth
- 4.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Growth
5 Americas
- 5.1 Americas Bio Similars/Subsequent Entry Biologic Market Size by Countries
- 5.2 Americas Bio Similars/Subsequent Entry Biologic Market Size by Type
- 5.3 Americas Bio Similars/Subsequent Entry Biologic Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Bio Similars/Subsequent Entry Biologic Market Size by Countries
- 6.2 APAC Bio Similars/Subsequent Entry Biologic Market Size by Type
- 6.3 APAC Bio Similars/Subsequent Entry Biologic Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Bio Similars/Subsequent Entry Biologic by Countries
- 7.2 Europe Bio Similars/Subsequent Entry Biologic Market Size by Type
- 7.3 Europe Bio Similars/Subsequent Entry Biologic Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic by Countries
- 8.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Type
- 8.3 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Bio Similars/Subsequent Entry Biologic Market Forecast
- 10.1 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast (2019-2024)
- 10.2 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions
- 10.2.1 Global Bio Similars/Subsequent Entry Biologic Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Bio Similars/Subsequent Entry Biologic Forecast by Type
- 10.8 Global Bio Similars/Subsequent Entry Biologic Forecast by Application
11 Key Players Analysis
- 11.1 Sun Pharma
- 11.1.1 Company Details
- 11.1.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Sun Pharma News
- 11.2 Synthon Pharmaceuticals
- 11.2.1 Company Details
- 11.2.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Synthon Pharmaceuticals News
- 11.3 Teva Pharmaceutical Industries
- 11.3.1 Company Details
- 11.3.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Teva Pharmaceutical Industries News
- 11.4 LG Life Sciences
- 11.4.1 Company Details
- 11.4.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 LG Life Sciences News
- 11.5 Celltrion Biocon
- 11.5.1 Company Details
- 11.5.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Celltrion Biocon News
- 11.6 Hospira
- 11.6.1 Company Details
- 11.6.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.6.3 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Hospira News
- 11.7 Merck
- 11.7.1 Company Details
- 11.7.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.7.3 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Merck News
- 11.8 Biogen idec
- 11.8.1 Company Details
- 11.8.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Biogen idec News
- 11.9 Genentech (Roche)
- 11.9.1 Company Details
- 11.9.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Genentech (Roche) News
- 11.10 Pfizer
- 11.10.1 Company Details
- 11.10.2 Bio Similars/Subsequent Entry Biologic Product Offered
- 11.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Pfizer News
- 11.11 Celltrion
- 11.12 Biocon
- 11.13 Amgen
- 11.14 Samsung Biologics
- 11.15 Mylan
- 11.16 Dr. Reddy's Laboratories
- 11.17 Stada Arzneimittel AG
- 11.18 AbbVie
- 11.19 Sanofi-Aventis
- 11.20 Johnson & Johnson
- 11.21 Novo Nordisk
- 11.22 Eli Lilly
- 11.23 Novartis
- 11.24 3sbio
- 11.25 Biotech
- 11.26 Gelgen
- 11.27 Innovent
- 11.28 Dong Bao
- 11.29 Ganlee
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Bio Similars/Subsequent Entry Biologic . Industry analysis & Market Report on Bio Similars/Subsequent Entry Biologic is a syndicated market report, published as Global Bio Similars/Subsequent Entry Biologic Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Bio Similars/Subsequent Entry Biologic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
